{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:19:29Z","timestamp":1792059569216,"version":"4.4.0"},"reference-count":45,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,3,1]]},"DOI":"10.1248\/bpb.b22-00833","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T22:12:08Z","timestamp":1677622328000},"page":"446-454","source":"Crossref","is-referenced-by-count":9,"title":["Enhancement of Neprilysin Activity by Natural Polyphenolic Compounds and Their Derivatives in Cultured Neuroglioma Cells"],"prefix":"10.1248","volume":"46","author":[{"given":"Yuma","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa S. A.","family":"Yassen","sequence":"additional","affiliation":[{"name":"Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University"},{"name":"Department of Pharmaceutical Organic Chemistry, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiro","family":"Shirotani","sequence":"additional","affiliation":[{"name":"Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Natural Product Chemistry, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University"},{"name":"Leading Medical Research Core Unit, Graduate School of Biomedical Sciences, Nagasaki University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Karran E, De Strooper B. The amyloid cascade hypothesis: are we poised for success or failure? <i>J. Neurochem.<\/i>, <b>139<\/b> (Suppl. 2), 237\u2013252 (2016).","DOI":"10.1111\/jnc.13632"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hardy JA, Higgins GA. Alzheimer\u2019s disease\u202f: the amyloid cascade hypothesis. <i>Science<\/i>, <b>256<\/b>, 184\u2013185 (1992).","DOI":"10.1126\/science.1566067"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hardy J. The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal. <i>J. Neurochem.<\/i>, <b>110<\/b>, 1129\u20131134 (2009).","DOI":"10.1111\/j.1471-4159.2009.06181.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Demetrius LA, Magistretti PJ, Pellerin L. Alzheimer\u2019s disease: the amyloid hypothesis and the Inverse Warburg effect. <i>Front. Physiol.<\/i>, <b>5<\/b>, 522 (2015).","DOI":"10.3389\/fphys.2014.00522"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC. Identification of the major A\u03b2<sub>1-42<\/sub>-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. <i>Nat. Med.<\/i>, <b>6<\/b>, 143\u2013150 (2000).","DOI":"10.1038\/72237"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. Metabolic regulation of brain A\u03b2 by neprilysin. <i>Science<\/i>, <b>292<\/b>, 1550\u20131552 (2001).","DOI":"10.1126\/science.1059946"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yasojima K, Akiyama H, McGeer EG, McGeer PL. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of \u03b2-amyloid peptide. <i>Neurosci. Lett.<\/i>, <b>297<\/b>, 97\u2013100 (2001).","DOI":"10.1016\/S0304-3940(00)01675-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Wang DS, Iwata N, Hama E, Saido TC, Dickson DW. Oxidized neprilysin in aging and Alzheimer\u2019s disease brains. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>310<\/b>, 236\u2013241 (2003).","DOI":"10.1016\/j.bbrc.2003.09.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A. Neprylisin decreases uniformly in Alzheimer\u2019s disease and in normal aging. <i>FEBS Lett.<\/i>, <b>579<\/b>, 6027\u20136030 (2005).","DOI":"10.1016\/j.febslet.2005.09.054"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hellstr\u00f6m-Lindahl E, Ravid R, Nordberg A. Age-dependent decline of neprilysin in Alzheimer\u2019s disease and normal brain: inverse correlation with A\u03b2 levels. <i>Neurobiol. Aging<\/i>, <b>29<\/b>, 210\u2013221 (2008).","DOI":"10.1016\/j.neurobiolaging.2006.10.010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? <i>J. Med. Chem.<\/i>, <b>51<\/b>, 2589\u20132599 (2008).","DOI":"10.1021\/jm0704090"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chang X, Rong C, Chen Y, Yang C, Hu Q, Mo Y, Zhang C, Gu X, Zhang L, He W, Cheng S, Hou X, Su R, Liu S, Dun W, Wang Q, Fang S. (\u2212)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer\u2019s disease model mice by upregulating neprilysin expression. <i>Exp. Cell Res.<\/i>, <b>334<\/b>, 136\u2013145 (2015).","DOI":"10.1016\/j.yexcr.2015.04.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Corpas R, Gri\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Farr\u00e9 E, Pall\u00e0s M, Sanfeliu C. Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. <i>Mol. Neurobiol.<\/i>, <b>56<\/b>, 1502\u20131516 (2019).","DOI":"10.1007\/s12035-018-1157-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. <i>Neurochem. Int.<\/i>, <b>54<\/b>, 111\u2013118 (2009).","DOI":"10.1016\/j.neuint.2008.10.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zamora R, Aguilar I, Granvogl M, Hidalgo FJ. Toxicologically relevant aldehydes produced during the frying process are trapped by food phenolics. <i>J. Agric. Food Chem.<\/i>, <b>64<\/b>, 5583\u20135589 (2016).","DOI":"10.1021\/acs.jafc.6b02165"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K, Saido TC, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H. Anti-A\u03b2 drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer\u2019s disease. <i>PLoS ONE<\/i>, <b>6<\/b>, e25788 (2011).","DOI":"10.1371\/journal.pone.0025788"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Seki T, Kanagawa M, Kobayashi K, Kowa H, Yahata N, Maruyama K, Iwata N, Inoue H, Toda T. Galectin 3-binding protein suppresses amyloid-\u03b2 production by modulating \u03b2-cleavage of amyloid precursor protein. <i>J. Biol. Chem.<\/i>, <b>295<\/b>, 3678\u20133691 (2020).","DOI":"10.1074\/jbc.RA119.008703"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kawakubo T, Mori R, Shirotani K, Iwata N, Asai M. Neprilysin is suppressed by dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) in Down-syndrome-derived fibroblasts. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 327\u2013333 (2017).","DOI":"10.1248\/bpb.b16-00825"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Matiadis D, Ng ST, Chen EH, Nigianni G, Vidali VP, Canko A, Chen RP, Sagnou M. Synthesis and biological evaluation of hydroxylated monocarbonyl curcumin derivatives as potential inducers of neprilysin activity. <i>Biomedicines<\/i>, <b>9<\/b>, 955 (2021).","DOI":"10.3390\/biomedicines9080955"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L. Roles of resveratrol and other grape-derived polyphenols in Alzheimer\u2019s disease prevention and treatment. <i>Biochim. Biophys. Acta<\/i>, <b>1852<\/b>, 1202\u20131208 (2015).","DOI":"10.1016\/j.bbadis.2014.10.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Farkas O, Jakus J, H\u00e9berger K. Quantitative structure-antioxidant activity relationships of flavonoid compounds. <i>Molecules<\/i>, <b>9<\/b>, 1079\u20131088 (2004).","DOI":"10.3390\/91201079"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Shi ZH, Li NG, Tang YP, Wei-Li, Lian-Yin, Yang JP, Hao-Tang, Duan JA. Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. <i>Eur. J. Med. Chem.<\/i>, <b>54<\/b>, 210\u2013222 (2012).","DOI":"10.1016\/j.ejmech.2012.04.044"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. <i>Free Radic. Biol. Med.<\/i>, <b>20<\/b>, 933\u2013956 (1996).","DOI":"10.1016\/0891-5849(95)02227-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Sawai Y, Moon JH, Sakata K, Watanabe N. Effects of structure on radical-scavenging abilities and antioxidative activities of tea polyphenols: NMR analytical approach using 1,1-diphenyl-2-picrylhydrazyl radicals. <i>J. Agric. Food Chem.<\/i>, <b>53<\/b>, 3598\u20133604 (2005).","DOI":"10.1021\/jf040423a"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. <i>Food Chem. Toxicol.<\/i>, <b>46<\/b>, 1271\u20131278 (2008).","DOI":"10.1016\/j.fct.2007.10.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. <i>J. Biol. Chem.<\/i>, <b>276<\/b>, 22586\u201322594 (2001).","DOI":"10.1074\/jbc.M101846200"},{"key":"27","unstructured":"27) Cavet ME, Harrington KL, Vollmer TR, Ward KW, Zhang JZ. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. <i>Mol. Vis.<\/i>, <b>17<\/b>, 533\u2013542 (2011). \u2039https:\/\/pubmed.ncbi.nlm.nih.gov\/21364905\/\u203a"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. <i>Eur. J. Pharmacol.<\/i>, <b>636<\/b>, 1\u20137 (2010).","DOI":"10.1016\/j.ejphar.2010.03.043"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. <i>J. Neurochem.<\/i>, <b>78<\/b>, 1073\u20131082 (2001).","DOI":"10.1046\/j.1471-4159.2001.00490.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Cano A, Ettcheto M, Espina M, Auladell C, Calpena AC, Folch J, Barenys M, S\u00e1nchez-L\u00f3pez E, Camins A, Garc\u00eda ML. Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: a new anti-seizure strategy for temporal lobe epilepsy. <i>Nanomedicine<\/i>, <b>14<\/b>, 1073\u20131085 (2018).","DOI":"10.1016\/j.nano.2018.01.019"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT. Green tea (\u2212)-epigallocatechin-3-gallate inhibits \u03b2-amyloid-induced cognitive dysfunction through modification of secretase activity <i>via<\/i> inhibition of ERK and NF-\u03baB pathways in mice. <i>J. Nutr.<\/i>, <b>139<\/b>, 1987\u20131993 (2009).","DOI":"10.3945\/jn.109.109785"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kaur T, Pathak CM, Pandhi P, Khanduja KL. Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. <i>Brain Cogn.<\/i>, <b>67<\/b>, 25\u201330 (2008).","DOI":"10.1016\/j.bandc.2007.10.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak M, Yologlu S. Neuroprotection by resveratrol against traumatic brain injury in rats. <i>Mol. Cell. Biochem.<\/i>, <b>294<\/b>, 137\u2013144 (2007).","DOI":"10.1007\/s11010-006-9253-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Mi Y, Qi G, Fan R, Qiao Q, Sun Y, Gao Y, Liu X. EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS\/AKT and ERK\/CREB\/BDNF signaling pathways in the CNS. <i>FASEB J.<\/i>, <b>31<\/b>, 4998\u20135011 (2017).","DOI":"10.1096\/fj.201700400RR"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Hu Q, Chang X, Yan R, Rong C, Yang C, Cheng S, Gu X, Yao H, Hou X, Mo M, Zhao L, Chen Y, Dinlin X, Wang Q, Fang S. (\u2212)-Epigallocatechin-3-gallate induces cancer cell apoptosis <i>via<\/i> acetylation of amyloid precursor protein. <i>Med. Oncol.<\/i>, <b>32<\/b>, 390 (2015).","DOI":"10.1007\/s12032-014-0390-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Wang Z, Zhang XJ, Li T, Li J, Tang Y, Le W. Valproic acid reduces neuritic plaque formation and improves learning deficits in APP<sup>Swe<\/sup>\/PS1<sup>A246E<\/sup> transgenic mice <i>via<\/i> preventing the prenatal hypoxia-induced down-regulation of neprilysin. <i>CNS Neurosci. Ther.<\/i>, <b>20<\/b>, 209\u2013217 (2014).","DOI":"10.1111\/cns.12186"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ettcheto M, Abad S, Petrov D, Pedr\u00f3s I, Busquets O, S\u00e1nchez-L\u00f3pez E, Casades\u00fas G, Beas-Zarate C, Carro E, Auladell C, Olloquequi J, Pall\u00e0s M, Folch J, Camins A. Early preclinical changes in hippocampal CREB-binding protein expression in a mouse model of familial Alzheimer\u2019s disease. <i>Mol. Neurobiol.<\/i>, <b>55<\/b>, 4885\u20134895 (2018).","DOI":"10.1007\/s12035-017-0690-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Corpas R, Gri\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Farr\u00e9 E, Pall\u00e0s M, Sanfeliu C. Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. <i>Mol. Neurobiol.<\/i>, <b>56<\/b>, 1502\u20131516 (2019).","DOI":"10.1007\/s12035-018-1157-y"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Gao J, Wang WY, Mao YW, Gr\u00e4ff J, Guan JS, Pan L, Mak G, Kim D, Su SC, Tsai LH. A novel pathway regulates memory and plasticity <i>via<\/i> SIRT1 and miR-134. <i>Nature<\/i>, <b>466<\/b>, 1105\u20131109 (2010).","DOI":"10.1038\/nature09271"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Shen J, Xu L, Qu C, Sun H, Zhang J. Resveratrol prevents cognitive deficits induced by chronic unpredictable mild stress: Sirt1\/miR-134 signalling pathway regulates CREB\/BDNF expression in hippocampus <i>in vivo<\/i> and <i>in vitro.<\/i> <i>Behav. Brain Res.<\/i>, <b>349<\/b>, 1\u20137 (2018).","DOI":"10.1016\/j.bbr.2018.04.050"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Zhao L, Wang JL, Liu R, Li XX, Li JF, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer\u2019s disease mouse model. <i>Molecules<\/i>, <b>18<\/b>, 9949\u20139965 (2013).","DOI":"10.3390\/molecules18089949"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Zhang Y, Zhen W, Maechler P, Liu D. Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic \u03b2-cell survival and function <i>via<\/i> CREB. <i>J. Nutr. Biochem.<\/i>, <b>24<\/b>, 638\u2013646 (2013).","DOI":"10.1016\/j.jnutbio.2012.03.008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. <i>Cell<\/i>, <b>59<\/b>, 675\u2013680 (1989).","DOI":"10.1016\/0092-8674(89)90013-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, Suemoto T, Higuchi M, Saido TC. Somatostatin regulates brain amyloid \u03b2 peptide A\u03b2<sub>42<\/sub> through modulation of proteolytic degradation. <i>Nat. Med.<\/i>, <b>11<\/b>, 434\u2013439 (2005).","DOI":"10.1038\/nm1206"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Baba Y, Inagaki S, Nakagawa S, Kaneko T, Kobayashi M, Takihara T. Effect of daily intake of green tea catechins on cognitive function in middle-aged and older subjects: a randomized, placebo-controlled study. <i>Molecules<\/i>, <b>25<\/b>, 4265 (2020).","DOI":"10.3390\/molecules25184265"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/3\/46_b22-00833\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:51:10Z","timestamp":1715316670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/3\/46_b22-00833\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00833","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"article-number":"b22-00833"}}